Regulations on per- and polyfluoroalkyl substances (PFAS), known as ‘forever chemicals’, are tightening due to their environmental persistence and potential health risks. Found in consumer products and water sources, stricter guidelines aim to reduce exposure and safeguard public health.
August 2024 – ACS Publications
Key Takeaways
- PFAS exposure is linked to health risks that may impact longevity and overall well-being, raising concerns about their widespread presence in the environment: PFAS, often referred to as ‘forever chemicals’, are resistant to breakdown and can accumulate in the body over time. This persistence has been associated with various health issues, including endocrine disruption and potential implications for lifespan, making their presence a critical concern for those focused on healthy ageing
- Regulatory actions are intensifying to limit exposure to these persistent chemicals, emphasising the importance of reducing environmental and personal contact: Governments and regulatory bodies are implementing stricter guidelines to monitor and control PFAS usage. These measures aim to reduce human exposure and environmental contamination, reflecting a growing recognition of their long-term health implications and the need for precautionary action
- Consumer products and water sources are significant contributors to PFAS exposure, highlighting the need for vigilance in daily choices: Everyday items such as non-stick cookware, water-resistant clothing, and personal care products often contain PFAS. Contamination in water supplies further compounds exposure risks, suggesting that individuals should be mindful of product labels and consider filtration options to minimise intake
Reducing exposure to PFAS may lower the risk of their accumulation in tissues, potentially mitigating the adverse effects linked to these chemicals. This proactive approach aligns with strategies to promote longevity and maintain optimal health as we age.
Read the article at: Goldenman, Gretta, et al. “PFAS and Human Health: A Review of Key Concerns for Longevity and Ageing.” ACS Pharmacology & Translational Science, vol. 4, no. 1, 2024, doi:10.1021/acsptsci.4c00002.